Roof Boxes
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Chinese Patent Medicine Market Research Report 2023
1 Chinese Patent Medicine Market Overview
1.1 Product Overview and Scope of Chinese Patent Medicine
1.2 Chinese Patent Medicine Segment by Type
1.2.1 Global Chinese Patent Medicine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Chinese Patent Medicine Segment by Application
1.3.1 Global Chinese Patent Medicine Sales Comparison by Application: (2022-2028)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Chinese Patent Medicine Market Size Estimates and Forecasts
1.4.1 Global Chinese Patent Medicine Revenue 2017-2028
1.4.2 Global Chinese Patent Medicine Sales 2017-2028
1.4.3 Chinese Patent Medicine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Chinese Patent Medicine Market Competition by Manufacturers
2.1 Global Chinese Patent Medicine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Chinese Patent Medicine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Chinese Patent Medicine Manufacturing Sites, Area Served, Product Type
2.5 Chinese Patent Medicine Market Competitive Situation and Trends
2.5.1 Chinese Patent Medicine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chinese Patent Medicine Players Market Share by Revenue
2.5.3 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chinese Patent Medicine Retrospective Market Scenario by Region
3.1 Global Chinese Patent Medicine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Chinese Patent Medicine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Chinese Patent Medicine Market Facts & Figures by Country
3.3.1 North America Chinese Patent Medicine Sales by Country
3.3.2 North America Chinese Patent Medicine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chinese Patent Medicine Market Facts & Figures by Country
3.4.1 Europe Chinese Patent Medicine Sales by Country
3.4.2 Europe Chinese Patent Medicine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Region
3.5.1 Asia Pacific Chinese Patent Medicine Sales by Region
3.5.2 Asia Pacific Chinese Patent Medicine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chinese Patent Medicine Market Facts & Figures by Country
3.6.1 Latin America Chinese Patent Medicine Sales by Country
3.6.2 Latin America Chinese Patent Medicine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Country
3.7.1 Middle East and Africa Chinese Patent Medicine Sales by Country
3.7.2 Middle East and Africa Chinese Patent Medicine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chinese Patent Medicine Historic Market Analysis by Type
4.1 Global Chinese Patent Medicine Sales Market Share by Type (2017-2022)
4.2 Global Chinese Patent Medicine Revenue Market Share by Type (2017-2022)
4.3 Global Chinese Patent Medicine Price by Type (2017-2022)
5 Global Chinese Patent Medicine Historic Market Analysis by Application
5.1 Global Chinese Patent Medicine Sales Market Share by Application (2017-2022)
5.2 Global Chinese Patent Medicine Revenue Market Share by Application (2017-2022)
5.3 Global Chinese Patent Medicine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Shanghai Pharmaceutical (Group) Co., Ltd.
6.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
6.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
6.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.2 China Pharmaceutical Group Corporation
6.2.1 China Pharmaceutical Group Corporation Corporation Information
6.2.2 China Pharmaceutical Group Corporation Description and Business Overview
6.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
6.2.5 China Pharmaceutical Group Corporation Recent Developments/Updates
6.3 Guangzhou Pharmaceutical Group Co., Ltd.
6.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
6.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Tianjin Pharmaceutical Group Co., Ltd.
6.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Harbin Pharmaceutical Group Co., Ltd
6.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
6.5.2 Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
6.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
6.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
6.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
6.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
6.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
6.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
6.7 North China Pharmaceutical Group Co., Ltd.
6.6.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
6.6.2 North China Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.7.5 North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
6.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
6.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
6.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.9 Taiji Group Co., Ltd.
6.9.1 Taiji Group Co., Ltd. Corporation Information
6.9.2 Taiji Group Co., Ltd. Description and Business Overview
6.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.9.5 Taiji Group Co., Ltd. Recent Developments/Updates
6.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
6.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
6.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
6.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.11 Nanjing Pharmaceutical Co., Ltd
6.11.1 Nanjing Pharmaceutical Co., Ltd Corporation Information
6.11.2 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
6.11.5 Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Chongqing Pharmaceutical Co., Ltd
6.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
6.12.2 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
6.12.5 Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
6.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
6.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.14 Jiangxi Pharmaceutical Group Corporation
6.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
6.14.2 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Description and Business Overview
6.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
6.14.5 Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
6.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
6.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
6.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.16 Northeast Pharmaceutical Group Co., Ltd.
6.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
6.16.2 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Chinese Patent Medicine Manufacturing Cost Analysis
7.1 Chinese Patent Medicine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chinese Patent Medicine
7.4 Chinese Patent Medicine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chinese Patent Medicine Distributors List
8.3 Chinese Patent Medicine Customers
9 Chinese Patent Medicine Market Dynamics
9.1 Chinese Patent Medicine Industry Trends
9.2 Chinese Patent Medicine Market Drivers
9.3 Chinese Patent Medicine Market Challenges
9.4 Chinese Patent Medicine Market Restraints
10 Global Market Forecast
10.1 Chinese Patent Medicine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chinese Patent Medicine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Chinese Patent Medicine by Type (2023-2028)
10.2 Chinese Patent Medicine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chinese Patent Medicine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Chinese Patent Medicine by Application (2023-2028)
10.3 Chinese Patent Medicine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chinese Patent Medicine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Chinese Patent Medicine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Chinese Patent Medicine Sales Growth Rate Comparison by Type (2022-2028) & (K MT) & (US$ Million)
Table 2. Global Chinese Patent Medicine Sales Growth Rate Comparison by Application (2022-2028) & (K MT) & (US$ Million)
Table 3. Global Chinese Patent Medicine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Chinese Patent Medicine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Chinese Patent Medicine Sales (K MT) of Key Manufacturers (2017-2022)
Table 6. Global Chinese Patent Medicine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Chinese Patent Medicine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Chinese Patent Medicine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Chinese Patent Medicine Average Price (USD/MT) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Chinese Patent Medicine Manufacturing Sites and Area Served
Table 11. Manufacturers Chinese Patent Medicine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chinese Patent Medicine Sales by Region (2017-2022) & (K MT)
Table 16. Global Chinese Patent Medicine Sales Market Share by Region (2017-2022)
Table 17. Global Chinese Patent Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Chinese Patent Medicine Revenue Market Share by Region (2017-2022)
Table 19. North America Chinese Patent Medicine Sales by Country (2017-2022) & (K MT)
Table 20. North America Chinese Patent Medicine Sales Market Share by Country (2017-2022)
Table 21. North America Chinese Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Chinese Patent Medicine Revenue Market Share by Country (2017-2022)
Table 23. Europe Chinese Patent Medicine Sales by Country (2017-2022) & (K MT)
Table 24. Europe Chinese Patent Medicine Sales Market Share by Country (2017-2022)
Table 25. Europe Chinese Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Chinese Patent Medicine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Chinese Patent Medicine Sales by Region (2017-2022) & (K MT)
Table 28. Asia Pacific Chinese Patent Medicine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Chinese Patent Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Chinese Patent Medicine Sales by Country (2017-2022) & (K MT)
Table 32. Latin America Chinese Patent Medicine Sales Market Share by Country (2017-2022)
Table 33. Latin America Chinese Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Chinese Patent Medicine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Chinese Patent Medicine Sales by Country (2017-2022) & (K MT)
Table 36. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Chinese Patent Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country (2017-2022)
Table 39. Global Chinese Patent Medicine Sales by Type (2017-2022) & (K MT)
Table 40. Global Chinese Patent Medicine Sales Market Share by Type (2017-2022)
Table 41. Global Chinese Patent Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Chinese Patent Medicine Revenue Share by Type (2017-2022)
Table 43. Global Chinese Patent Medicine Price by Type (2017-2022) & (USD/MT)
Table 44. Global Chinese Patent Medicine Sales (K MT) by Application (2017-2022)
Table 45. Global Chinese Patent Medicine Sales Market Share by Application (2017-2022)
Table 46. Global Chinese Patent Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Chinese Patent Medicine Revenue Share by Application (2017-2022)
Table 48. Global Chinese Patent Medicine Price by Application (2017-2022) & (USD/MT)
Table 49. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 50. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 51. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 52. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product
Table 53. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 54. China Pharmaceutical Group Corporation Corporation Information
Table 55. China Pharmaceutical Group Corporation Description and Business Overview
Table 56. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 57. China Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 58. China Pharmaceutical Group Corporation Recent Developments/Updates
Table 59. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 60. Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 61. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 62. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 63. Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 64. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 65. Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 66. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 67. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 68. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 69. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 70. Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
Table 71. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 72. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product
Table 73. Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 74. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 75. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
Table 76. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 77. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product
Table 78. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
Table 79. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 80. North China Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 81. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 82. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 83. North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 84. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 85. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 86. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 87. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 88. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 89. Taiji Group Co., Ltd. Corporation Information
Table 90. Taiji Group Co., Ltd. Description and Business Overview
Table 91. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 92. Taiji Group Co., Ltd. Chinese Patent Medicine Product
Table 93. Taiji Group Co., Ltd. Recent Developments/Updates
Table 94. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 95. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 96. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 97. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 98. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 99. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 100. Nanjing Pharmaceutical Co., Ltd Description and Business Overview
Table 101. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 102. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 103. Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 104. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 105. Chongqing Pharmaceutical Co., Ltd Description and Business Overview
Table 106. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 107. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 108. Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 109. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 110. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 111. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 112. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 113. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 114. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 115. Jiangxi Pharmaceutical Group Corporation Description and Business Overview
Table 116. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 117. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 118. Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
Table 119. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 120. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 121. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 122. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 123. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 124. Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table 125. Northeast Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 126. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 127. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 128. Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. Chinese Patent Medicine Distributors List
Table 132. Chinese Patent Medicine Customers List
Table 133. Chinese Patent Medicine Market Trends
Table 134. Chinese Patent Medicine Market Drivers
Table 135. Chinese Patent Medicine Market Challenges
Table 136. Chinese Patent Medicine Market Restraints
Table 137. Global Chinese Patent Medicine Sales Forecast by Type (2023-2028) & (K MT)
Table 138. Global Chinese Patent Medicine Sales Market Share Forecast by Type (2023-2028)
Table 139. Global Chinese Patent Medicine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 140. Global Chinese Patent Medicine Revenue Market Share Forecast by Type (2023-2028)
Table 141. Global Chinese Patent Medicine Sales Forecast by Application (2023-2028) & (K MT)
Table 142. Global Chinese Patent Medicine Sales Market Share Forecast by Application (2023-2028)
Table 143. Global Chinese Patent Medicine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 144. Global Chinese Patent Medicine Revenue Market Share Forecast by Application (2023-2028)
Table 145. Global Chinese Patent Medicine Sales Forecast by Region (2023-2028) & (K MT)
Table 146. Global Chinese Patent Medicine Sales Market Share Forecast by Region (2023-2028)
Table 147. Global Chinese Patent Medicine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 148. Global Chinese Patent Medicine Revenue Market Share Forecast by Region (2023-2028)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chinese Patent Medicine
Figure 2. Global Chinese Patent Medicine Market Share by Type in 2021 & 2028
Figure 3. Syrup Product Picture
Figure 4. Liquid Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chinese Patent Medicine Market Share by Application in 2021 & 2028
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Global Chinese Patent Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Chinese Patent Medicine Market Size (2017-2028) & (US$ Million)
Figure 12. Global Chinese Patent Medicine Sales (2017-2028) & (K MT)
Figure 13. Chinese Patent Medicine Sales Share by Manufacturers in 2021
Figure 14. Global Chinese Patent Medicine Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Chinese Patent Medicine Players: Market Share by Revenue in 2021
Figure 16. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Chinese Patent Medicine Sales Market Share by Region (2017-2022)
Figure 18. Global Chinese Patent Medicine Sales Market Share by Region in 2021
Figure 19. Global Chinese Patent Medicine Revenue Market Share by Region (2017-2022)
Figure 20. Global Chinese Patent Medicine Revenue Market Share by Region in 2021
Figure 21. U.S. Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. U.A.E Chinese Patent Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Chinese Patent Medicine by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Chinese Patent Medicine
Figure 47. Manufacturing Process Analysis of Chinese Patent Medicine
Figure 48. Chinese Patent Medicine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shanghai Pharmaceutical (Group) Co., Ltd. China Pharmaceutical Group Corporation Guangzhou Pharmaceutical Group Co., Ltd. Tianjin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd Nanjing Pharmaceutical Industry (Group) Co., Ltd. North China Pharmaceutical Group Co., Ltd. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Taiji Group Co., Ltd. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Nanjing Pharmaceutical Co., Ltd Chongqing Pharmaceutical Co., Ltd Hangzhou Huadong Pharmaceutical Group Co., Ltd. Jiangxi Pharmaceutical Group Corporation Shijiazhuang Pharmaceutical Group Co., Ltd. Northeast Pharmaceutical Group Co., Ltd.